1. Points to consider: The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products;Anon.,1997
2. Note for guidance on safety pharmacology studies for human pharmaceuticals;Anon.,2000
3. ICH harmonised tripartite guideline;Anon.,2005
4. 24-hour ambulatory electrocardiography in the dog;Birettoni;Veterinary Research Communications,2004
5. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers;Carmeliet;Journal of Pharmacology & Experimental Therapeutics,1985